Development of Delpazolid for the Treatment of Tuberculosis

A novel oxazolidinone with cyclic amidrazone, delpazolid (LCB01-0371), was synthesized by LegoChem BioSciences, Inc. (Daejeon, Korea). Delpazolid can improve the minimum bactericidal concentration of <i>Mycobacterium tuberculosis </i>H37Rv and significantly reduce resistance rates, espec...

Full description

Bibliographic Details
Main Authors: Young Lag Cho, Jichan Jang
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/10/7/2211